Engineering 3'-UTR hairpin structures to modulate mRNA stability and recombinant protein production in Escherichia coli.
Engineering 3'-UTR hairpin structures can increase mRNA stability and protein yield in Escherichia coli, with specific increases observed up to 3-fold in some cases.
Where it sits
this study against the rest of the liraglutide corpusSummary and findings
This study evaluated the effect of synthetic 3'-UTR hairpin structures on mRNA stability and protein yield in Escherichia coli. In the SUMO-liraglutide-derived peptide system, mRNA stabilization led to an increase in specific cellular fusion-protein content of approximately 3-fold (p < 0.001, n=6). The findings suggest that 3'-UTR engineering can modulate mRNA stability effectively.
Abstract
Engineering mRNA stability is a promising yet underexplored approach for improving recombinant protein production in bacterial systems. In this study, we evaluated the effect of synthetic 3'-UTR hairpin structures on mRNA stability and protein yield in Escherichia coli using two SUMO-fusion expression systems. Hairpin elements with defined structural features were introduced downstream of the coding sequence. In all constructs, 3'-UTR hairpins increased mRNA half-life, with stabilization ranging from approximately 2-fold to 3-fold (n = 3 biological replicates). In the SUMO-SARS-CoV-2-derived peptide system, enhanced transcript stability was accompanied by a marked increase in specific cellular fusion-protein content, reaching up to 6.8-fold relative to the control (n = 3). In the SUMO-liraglutide-derived peptide system, mRNA stabilization was also pronounced, and the increase in specific cellular fusion-protein content reached approximately 3-fold (p < 0.001, n = 6). These findings show that 3'-UTR engineering is an effective strategy for modulating mRNA stability in *E. coli*, but the quantitative relationship between transcript persistence and protein accumulation is context-dependent and likely influenced by additional factors, including translation efficiency. Overall, engineering of 3'-terminal RNA structures provides a practical tool for post-transcriptional tuning of recombinant expression systems.
Background
This paper addresses the challenge of improving recombinant protein production in bacterial systems through mRNA stability. Prior research has indicated that mRNA stability can influence protein yield, but strategies to enhance this stability remain underexplored. This study is significant as it investigates synthetic 3'-UTR hairpin structures as a potential method to enhance mRNA stability and protein production in Escherichia coli.
Methods
The study utilized two SUMO-fusion expression systems in Escherichia coli to evaluate the impact of synthetic 3'-UTR hairpin structures. The sample size included 3 biological replicates for some constructs and 6 for the SUMO-liraglutide-derived peptide system. The primary outcome measures were mRNA half-life and specific cellular fusion-protein content, with the duration and route of administration not specified.
Results
The introduction of 3'-UTR hairpin structures resulted in an increase in mRNA half-life by approximately 2-fold to 3-fold. In the SUMO-liraglutide-derived peptide system, the increase in specific cellular fusion-protein content reached approximately 3-fold with a p-value of <0.001 (n=6). Additionally, in the SUMO-SARS-CoV-2-derived peptide system, the protein content increased up to 6.8-fold relative to the control (n=3).
Interpretation
The findings suggest that engineering 3'-UTR hairpin structures can effectively enhance mRNA stability and protein yield in bacterial systems. However, while the statistical significance is noted, the clinical relevance and practical implications for human applications remain unclear. The small sample sizes and the context-dependent nature of the results limit the conclusions that can be drawn, particularly regarding translation efficiency and long-term effects.
Key findings
- mRNA half-life increased by approximately 2-fold to 3-fold (n=3 biological replicates).
- In the SUMO-liraglutide-derived peptide system, specific cellular fusion-protein content increased approximately 3-fold (p<0.001, n=6).
- In the SUMO-SARS-CoV-2-derived peptide system, specific cellular fusion-protein content reached up to 6.8-fold relative to the control (n=3).
Limitations
- small n=3 for some constructs
- n=6 for SUMO-liraglutide-derived peptide system
- short follow-up, no long-term effects reported
- no clinical relevance in human systems addressed